Pharmacolog has today approved DrugLog® software version 4.5 for official release. The software has undergone extensive development and includes several new features and improved workflow.
The new DrugLog® 4.5 software introduces a whole new user experience based on a guided workflow where every step of the quality assurance procedure is clearly indicated to the user. The graphical user interface is not only optimized for efficiency and safety, but also provides improved usability during the actual verification of the prepared drug. The system also allows for increased analysis of the test result by easy access to the spectrometric profile of the sample. Something that enables improved and quick decision-making.
DrugLog® version 4.5 also means improved data integrity and traceability through a new login feature in the application. By introducing DrugLog® 4.5 with its new tools, based on feedback from Pharmacolog’s customers, the application is now even more future-proof and effective for daily use in quality assurance of drug preparations.
Lars Gusch, Head of Development, comments: “The launch of DrugLog® 4.5 is an important step forward in improving the standard for quality control of liquid drugs in the medication process. DrugLog® is a unique, CE certified medical technology product, the only one that can quickly and easily verify that a drug preparation is accurate. I am convinced that our customers will greatly appreciate the improved concepts in the new software for faster, more reliable and more efficient measurements.”
For more information contact:
Mats Högberg, CEO
Email: mats.hogberg@pharmacolog.com
Phone: +46 70-546 50 21
About Pharmacolog AB
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.
Release